# The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes

> **NCT07097415** · NA · RECRUITING · sponsor: **Peking University** · enrollment: 600 (estimated)

## Conditions studied

- Continuous Glucose Monitoring
- Type 2 Diabetes (T2DM)

## Interventions

- **DEVICE:** Continuous blood glucose monitoring assisted blood glucose management

## Key facts

- **NCT ID:** NCT07097415
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07097415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07097415, "The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07097415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*